Search

A new inorganic-organic hybrid heterometallic compound, namely {[(CH3)2NH2][CdNa(4,4′-bpdc)2]}n·6n(H2O) (1, 4,4′-H2bpdc is 4,4′-biphenyldicarboxylic acid), was synthesized through the solvothermal self-assembly reactions of 4,4′-H2bpdc ligand in combination with Cd(II) and Na(I) salts. importantly, compound 1 shows high selectivity and sensitivity for the detection of acetylacetone (Hacac) molecule with a high Ksv value of 11.667 nM−1. Its prevention activity on osteoarthritis after the reconstruction of anterior cruciate ligament was investigated and the associated mechanism was analyzed. At first, the enzyme linked immunosorbent assay (ELISA) detection was implemented in the current research to detect the Interleukin-1β (IL-1β) and Interleukin-1β (IL-18) content released into joint cavity after treated with the compound. The results showed that this complex was good at inhibiting the IL-1β and IL-18 content released into joint cavity. The real time reverse transcription-polymerase chain reaction (RT-PCR) was carried out and the nuclear factor kappa-B (NF-κB) signaling pathway activation in joint soft tissue was tested exploiting real time RT-PCR. The real time RT-PCR exhibited that the NF-κB signaling pathway activation in the joint soft tissue was significantly reduced by the new compound. Subsequently, the levels of cartilage tissue cell apoptosis were also tested through Annexin V-FITC Apoptosis detection, and the results suggested the cartilage tissue cell apoptosis levels were obviously reduced by the compound. [ABSTRACT FROM AUTHOR]

Purpose: It is an open question whether cell transplantation can provide safety and effective outcome to spinal cord injury (SCI) patient which has remained controversial for almost 40 years. This study aimed to evaluate the safety and efficacy of cell transplantation in SCI patients.Method: Studies of the cell transplantation for SCI were retrieved from PubMed, Embase, Medline, Cochrane Library and analyzed quantitative data by Review Manager 5.3.Results: Twenty-one clinical controlled studies with 973 patients were included. The pooled results suggested that cell transplantation significantly improved ASIA score, ASIA motor score, ASIA sensory score, Barthel Index score, residual urine volume, rehabilitative time of automatic micturition. Furthermore, subgroup analysis indicated that the stem cells exhibited more potent than the non-stem cells in spinal cord repair. Cell transplantation at more than 14 days after injury showed more significant improvements than that within 14 days from injury. The dosage of cell transplantation between 1-5 × 107 and 10-20 × 107 was the potent quantity for the patient with SCI. Intrathecal injection and intravenous + intrathecal injection showed more superior to the other method. The top 5 adverse events were febrile reaction (11.5%), neurologic pain (11.3%), headache (2.6%), neurologic deterioration (2.4%), and rigidity or spasticity (1.6%).Conclusion: Cell transplantation appears to be a safe therapeutic strategy possessing substantial beneficial effects in the patients with SCI in clinic. Moreover, treating SCI with stem cell, the dosage of cells between 1-5 × 107 and 10-20 × 107, in intermediate or chronic phase, minimally invasive techniques, may bring more advantage to SCI patient. These slides can be retrieved under Electronic Supplementary Material. [ABSTRACT FROM AUTHOR]

Zhao-he and Sun-qingling are the co-first authors for this manuscript in the initial submission. Because of author's negligence and fault, this information was not shown clearly in the originally published article. [ABSTRACT FROM AUTHOR]